Chartwell Investment Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-37,059
Closed -$932K 438
2018
Q4
$932K Sell
37,059
-20,663
-36% -$531K 0.03% 402
2018
Q3
$1.67M Buy
+57,722
New +$1.08M 0.05% 407

Other funds holding CDNA

Chartwell Investment Partners's CDNA Position: Q1 2019 in Review

Chartwell Investment Partners sold out of CareDx (CDNA) in Q1 2019, closing a stake of 37,059 shares — an estimated $932K sold.

Chartwell Investment Partners first reported a position in CDNA in Q3 2018 and held it in 2 quarters. The position peaked at $1.67M in Q3 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • Chartwell Investment Partners reported no remaining CareDx position as of Q1 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 37,059 CareDx shares in Q1 2019, an estimated $932K.
  • Chartwell Investment Partners first reported a position in CareDx in Q3 2018 and held it in 2 quarters.
  • Chartwell Investment Partners's CareDx position peaked at $1.67M in Q3 2018.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on Chartwell Investment Partners's 13F filing for Q1 2019, filed 11 Apr 2019.